We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Avoid Investing in Xylem Stock Right Now
Read MoreHide Full Article
Xylem Inc. (XYL - Free Report) has failed to impress investors with its recent operational performance due to softness in the Applied Water segment. Also, increasing expenses are likely to impede the company’s earnings in the quarters ahead.
Headquartered in Rye Brook, NY, Xylem is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including the collection, distribution and return of water to the environment. It has a significant presence in the United States, the Asia Pacific, Europe and various other nations.
In the past year, this Zacks Rank #4 (Sell) company’s shares have gained 19% compared with the industry’s 30.3% growth.
Image Source: Zacks Investment Research
Let’s discuss the factors, which are likely to continue taking a toll on this company.
Segment Weakness: Xylem has been experiencing weakness in the Applied Water segment owing to a decrease in demand for industrial and building solutions applications including pumps, valves, heat exchangers, controls and dispensing equipment. Amid these challenges, the segment’s third-quarter revenues declined 4% on a year-over-year basis. A reduced number of project wins is likely to impact the segment’s performance in the near term. The lapping of large capital projects in the United States is ailing the Water Solutions and Services segment. The segment’s sales declined 2% year over year in the third quarter of 2024.
Increasing Costs: Xylem has been grappling with the adverse impacts of cost inflation. In the first nine months of 2024, the company’s cost of revenues increased 20.3% year over year due to high raw material, labor, freight and overhead costs. Selling, general and administrative expenses surged 8.8% due to additional operational expenditure from the acquisition of Evoqua. Escalating costs pose a threat to the company’s bottom line.
Forex Woes: The company has a significant presence in the international markets. As a result, its financial performance is subject to various risks like the foreign currency exchange rate, interest rate fluctuations and hyperinflation in some foreign countries. The increased value of the U.S. dollar relative to the local currencies of the foreign markets may affect the company’s top line in the quarters ahead.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 earnings has increased 8.4%.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 0.5%.
Kadant Inc. (KAI - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 17.2%.
The Zacks Consensus Estimate for KAI’s 2024 earnings has increased 1.8% in the past 60 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why You Should Avoid Investing in Xylem Stock Right Now
Xylem Inc. (XYL - Free Report) has failed to impress investors with its recent operational performance due to softness in the Applied Water segment. Also, increasing expenses are likely to impede the company’s earnings in the quarters ahead.
Headquartered in Rye Brook, NY, Xylem is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including the collection, distribution and return of water to the environment. It has a significant presence in the United States, the Asia Pacific, Europe and various other nations.
In the past year, this Zacks Rank #4 (Sell) company’s shares have gained 19% compared with the industry’s 30.3% growth.
Image Source: Zacks Investment Research
Let’s discuss the factors, which are likely to continue taking a toll on this company.
Segment Weakness: Xylem has been experiencing weakness in the Applied Water segment owing to a decrease in demand for industrial and building solutions applications including pumps, valves, heat exchangers, controls and dispensing equipment. Amid these challenges, the segment’s third-quarter revenues declined 4% on a year-over-year basis. A reduced number of project wins is likely to impact the segment’s performance in the near term. The lapping of large capital projects in the United States is ailing the Water Solutions and Services segment. The segment’s sales declined 2% year over year in the third quarter of 2024.
Increasing Costs: Xylem has been grappling with the adverse impacts of cost inflation. In the first nine months of 2024, the company’s cost of revenues increased 20.3% year over year due to high raw material, labor, freight and overhead costs. Selling, general and administrative expenses surged 8.8% due to additional operational expenditure from the acquisition of Evoqua. Escalating costs pose a threat to the company’s bottom line.
Forex Woes: The company has a significant presence in the international markets. As a result, its financial performance is subject to various risks like the foreign currency exchange rate, interest rate fluctuations and hyperinflation in some foreign countries. The increased value of the U.S. dollar relative to the local currencies of the foreign markets may affect the company’s top line in the quarters ahead.
Stocks to Consider
Some better-ranked companies are discussed below.
Graham Corporation (GHM - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 earnings has increased 8.4%.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 0.5%.
Kadant Inc. (KAI - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 17.2%.
The Zacks Consensus Estimate for KAI’s 2024 earnings has increased 1.8% in the past 60 days.